TABLE 1.

Comparison of M-capture ELISA results with other Lyme test results of other assays for LD for patient samples from patients with primary and secondary LD^a

Type of LD and patient	Culture for B. burgdorferi	M-capture ELISA result with the following:			Result of IFA for IgM	Result of EIA (recombinanti dot blot) for IgM	Result of immunoblotting for IgM	Result of polyvalent EIA
		Sonicate + flagellin (IC)	Sonicate (IC-derived antibody)	Sonicate (free antibody)
Secondary
MC-2	POS	POS	POS	POS	POS	POS	NEG	POS
MC-10	POS	POS	POS	POS	POS	POS	NEG	POS
MC-23	POS	POS	NEG	NEG	POS	POS	POS	POS
MC-28	POS	POS	POS	ND	POS	POS	POS	POS
MC-20	POS	POS	POS	ND	POS	POS	POS	POS
MC-3	POS	POS	POS	ND	POS	NEG	NEG	NEG
MC-14	POS	POS	POS	ND	POS	POS	POS	POS
MC-9	POS	POS	POS	ND	POS	POS	NEG	POS
MC-41	POS	POS	POS	NEG	POS	EQUIV	NEG	POS
Primary
MC-11	POS	EQUIV	EQUIV	NEG	POS	NEG	NEG	NEG
MC-35	POS	POS	POS	POS	NEG	EQUIV	POS	NEG
MC-48	POS	POS	POS	POS	POS	NEG	NEG	NEG
MC-55	POS	POS	POS	POS	POS	EQUIV	POS	NEG
MC-4	POS	POS	POS	ND	NEG	NEG	NEG	NEG
MC-17	POS	POS	NEG	ND	POS	NEG	NEG	POS
MC-36	POS	POS	POS	ND	NEG	POS	POS	POS
MC-72	POS	POS	POS	ND	EQUIV	NEG	POS	POS
MC-25	POS	POS	EQUIV	POS	POS	NEG	NEG	NEG
MC-24	POS	NEG	NEG	NEG	POS	NEG	NEG	NEG
MC-8	POS	NEG	NEG	ND	NEG	NEG	NEG	NEG

^aAlthough results are presented for the M-capture ELISA done in three ways, the direct comparison to other tests for LD should be done with the serum sample containing IC-derived antibody and assayed with the biotinylated whole-cell sonicate (Bb-bio) plus the biotinylated flagellin synthetic epitope-BSA carrier (Fla-bio) as the antigen source. The other Lyme tests for LD are described in Materials and Methods. POS, positive; NEG, negative; EQUIV, equivocal; ND, not determined.